STAAR Surgical Announces Second Quarter 2009 Earnings Release Date And Conference Call
Company's Cash Position Improves
"One of our 2009 key metrics is to focus on profitable growth and
operational efficiencies," said
The Company will host a conference call and webcast on
A taped replay of the conference call will also be available beginning
approximately one hour after the call's conclusion and will be available for
seven days. This replay can be accessed by dialing 800-406-7325 for domestic
callers and 303-590-3030 for international callers, both using passcode
4058578#. To access the live webcast of the call, go to
About
STAAR is a leader in the development, manufacture and marketing of
minimally invasive ophthalmic products employing proprietary technologies.
STAAR's products are used by ophthalmic surgeons and include the Visian ICL, a
tiny, flexible lens implanted to correct refractive errors, as well as
innovative products designed to improve patient outcomes for cataracts and
glaucoma. Manufactured in
Safe Harbor
The data included in this release regarding STAAR's cash position as of
the end of the second fiscal quarter is preliminary and remains subject to
review by STAAR's independent registered public accountants in connection with
the preparation of STAAR's consolidated balance sheet as of
CONTACT: Investors Media EVC Group EVC Group Doug Sherk Chris Gale Mike Pollock 646-201-5431 415-896-5862
SOURCE
CONTACT: Investors,
Media,
Company
Web Site: http://www.staar.com
(STAA)